Abstract:Abstract Background: Recent genome-wide profiling by sequencing and distinctive chromatin signatures has identified thousands of long intergenic non-coding RNA (lincRNA) species (>200 nt). LincRNAs are emerging as important regulators of gene expression. While altered expressions of lincRNAs have been observed to play an important role in tumorigenesis, their roles in breast cancer (BCa) progression and metastasis are still poorly understood. Experimental designs and results: To discover novel BCa-associated lincRNA transcripts, we have employed a high-density SNP array based approach, in which we specifically probed the transcripts in the human intergenic region to globally explore lincRNA genes that are aberrantly expressed in BCa. We found 38 lincRNA transcripts that were dysregulated in tumors (P<0.01, FDR2-fold change, vs. adjacent normal samples), including 22 lincRNAs being up-regulated, and 16 lincRNAs being down-regulated. One of the lincRNAs, termed LincIN, was probed by 5 exon-targeted markers, showing significant upregulation of expression in breast tumors (P<0.001). Results from BCa tissue microarray (TMA) analysis by RNAscope® ISH demonstrated that high LincIN expression in BCa tissues correlated with poorly differentiated tumor grade (vs. moderately and well differentiated grade, P<0.05). Furthermore, knockdown of LincIN in BCa cells diminished cancer cell migration and invasion in vitro and reduced lung metastasis in MDA-MB-231-luc-D3H1 xenografted mice, while overexpression of LincIN tended to promote BCa cell migration in vitro. Using RNA pull-down and subsequent mass spectrometry (MS), we identified and validated that NF90/ILF3 is one of the most abundant LincIN binding partners. NF90/ILF3 is a well-known double-stranded RNA-binding protein and participates in the post-transcriptional regulation of many genes, including p21. Overexpression of LincIN in MCF10A cells significantly decreased the p21 protein level but not the static p21 mRNA level, suggesting a potential role of LincIN in post-transcriptional regulation of p21. Importantly, the effect of LincIN-mediated downregulation of p21 protein was diminished when NF90 was reduced by RNAi. These results suggested that LincIN may regulate breast tumor progression/metastasis via mediating the NF90/ILF3-associated post-transcriptional regulation. Conclusions: Results from our clinical correlative analysis and functional studies support that LincIN is a promising prognostic RNA marker for BCa progression/metastasis. Knockdown of LincIN in BCa cells diminished cancer cell invasion in vitro and reduced lung metastasis in vivo, suggesting that LincIN could be a novel target for treating advanced BCa disease. This work was partially supported by the Susan G. Komen for the Cure (KG100274), and Eileen Stein Jacoby Fund. Citation Format: Zhengyu Jiang, Zhou Yan, Karthikeyan Devarajan, Carolyn M. Slater, Mary B. Daly, Xiaowei Chen. A novel metastasis-associating LincRNA destabilizes tumor-suppressor mRNAs through cooperative action with NF90/ILF3 binding. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2870. doi:10.1158/1538-7445.AM2015-2870

A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

A novel long non‐coding RNA LINC00524 facilitates invasion and metastasis through interaction with TDP43 in breast cancer

The Long Noncoding RNA AATBC Promotes Breast Cancer Migration and Invasion by Interacting with YBX1 and Activating the YAP1/Hippo Signaling Pathway.

Abstract 2870: A Novel Metastasis-Associating LincRNA Destabilizes Tumor-Suppressor Mrnas Through Cooperative Action with NF90/ILF3 Binding

Long Noncoding RNA Linc00460 Promotes Breast Cancer Progression by Regulating the Mir-489-5p/fgf7/akt Axis

LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 Axis

LINC02273 Drives Breast Cancer Metastasis by Epigenetically Increasing AGR2 Transcription

Long non-coding RNAs AC026904.1 and UCA1: a “one-two punch” for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer

LncRNA AC020978 facilitates non–small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway

Long Non-Coding RNA LINC00467 Correlates to Poor Prognosis and Aggressiveness of Breast Cancer

Abstract P1-05-08: LINC00926 Interacts with HNRNPC and Suppress Metastasis in Breast Cancer

LncRNA LGALS8-AS1 Promotes Breast Cancer Metastasis Through miR-125b-5p/SOX12 Feedback Regulatory Network

LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer

LINC01503 in cancer: from molecular mechanisms to therapeutic implications

LncRNA AC010789.1 Promotes Colorectal Cancer Progression by Targeting MicroRNA-432-3p/ZEB1 Axis and the Wnt/β-Catenin Signaling Pathway

LINC00882, Transcriptionally Activated by CEBP-β and Post-Transcriptionally Stabilized by METTL14-mediated M6a Modification, Exerts Tumorigenesis by Promoting PABPC1-mediated Stabilization of ELK3 Mrna

Long Non‐coding RNA ZEB2‐AS1 Promotes the Proliferation, Metastasis and Epithelial Mesenchymal Transition in Triple‐negative Breast Cancer by Epigenetically Activating ZEB2

Novel long non-codingRNA LINC02323promotes epithelial-mesenchymal transition and metastasis via spongingmiR-1343-3p in lung adenocarcinoma

Linc00152 Promotes Tumorigenesis by Regulating DNMTs in Triple-Negative Breast Cancer

The Role of Lncrnas in the Distant Metastasis of Breast Cancer